[HTML][HTML] Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses
AB Vogel, L Lambert, E Kinnear, D Busse, S Erbar… - Molecular Therapy, 2018 - cell.com
New vaccine platforms are needed to address the time gap between pathogen emergence
and vaccine licensure. RNA-based vaccines are an attractive candidate for this role: they are …
and vaccine licensure. RNA-based vaccines are an attractive candidate for this role: they are …
[PDF][PDF] Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
AB Vogel, L Lambert, E Kinnear, D Busse… - Molecular …, 2018 - scienceopen.com
New vaccine platforms are needed to address the time gap between pathogen emergence
and vaccine licensure. RNA-based vaccines are an attractive candidate for this role: they are …
and vaccine licensure. RNA-based vaccines are an attractive candidate for this role: they are …
[HTML][HTML] Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
AB Vogel, L Lambert, E Kinnear, D Busse, S Erbar… - Molecular Therapy, 2018 - Elsevier
New vaccine platforms are needed to address the time gap between pathogen emergence
and vaccine licensure. RNA-based vaccines are an attractive candidate for this role: they are …
and vaccine licensure. RNA-based vaccines are an attractive candidate for this role: they are …
[引用][C] Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
AB Vogel, L Lambert, E Kinnear, D Busse, S Erbar… - Molecular …, 2018 - cir.nii.ac.jp
Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA
Vaccines but at Much Lower Doses | CiNii Research CiNii 国立情報学研究所 学術情報 …
Vaccines but at Much Lower Doses | CiNii Research CiNii 国立情報学研究所 学術情報 …
[PDF][PDF] Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
AB Vogel, L Lambert, E Kinnear, D Busse… - Molecular …, 2018 - academia.edu
New vaccine platforms are needed to address the time gap between pathogen emergence
and vaccine licensure. RNA-based vaccines are an attractive candidate for this role: they are …
and vaccine licensure. RNA-based vaccines are an attractive candidate for this role: they are …
[PDF][PDF] Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
AB Vogel, L Lambert, E Kinnear, D Busse… - Molecular …, 2018 - researchgate.net
New vaccine platforms are needed to address the time gap between pathogen emergence
and vaccine licensure. RNA-based vaccines are an attractive candidate for this role: they are …
and vaccine licensure. RNA-based vaccines are an attractive candidate for this role: they are …
[HTML][HTML] Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
AB Vogel, L Lambert, E Kinnear, D Busse, S Erbar… - Molecular Therapy, 2018 - cell.com
New vaccine platforms are needed to address the time gap between pathogen emergence
and vaccine licensure. RNA-based vaccines are an attractive candidate for this role: they are …
and vaccine licensure. RNA-based vaccines are an attractive candidate for this role: they are …
Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses.
AB Vogel, L Lambert, E Kinnear, D Busse… - … Therapy: the Journal …, 2017 - europepmc.org
New vaccine platforms are needed to address the time gap between pathogen emergence
and vaccine licensure. RNA-based vaccines are an attractive candidate for this role: they are …
and vaccine licensure. RNA-based vaccines are an attractive candidate for this role: they are …
Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
AB Vogel, L Lambert, E Kinnear… - … therapy: the journal …, 2018 - pubmed.ncbi.nlm.nih.gov
New vaccine platforms are needed to address the time gap between pathogen emergence
and vaccine licensure. RNA-based vaccines are an attractive candidate for this role: they are …
and vaccine licensure. RNA-based vaccines are an attractive candidate for this role: they are …
[PDF][PDF] Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
AB Vogel, L Lambert, E Kinnear, D Busse, S Erbar… - Molecular …, 2018 - core.ac.uk
New vaccine platforms are needed to address the time gap between pathogen emergence
and vaccine licensure. RNA-based vaccines are an attractive candidate for this role: they are …
and vaccine licensure. RNA-based vaccines are an attractive candidate for this role: they are …